BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for UNUM THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-16 5:11 pm Purchase | 2020-07-06 | 13G | UNUM THERAPEUTICS INC UMRX | BIOTECHNOLOGY VALUE FUND L P | 4,154,000 9.990% | 4,154,000 (New Position) | Filing |